tiprankstipranks
Trending News
More News >
Akebia Therapeutics (AKBA)
NASDAQ:AKBA

Akebia Therapeutics (AKBA) Similar Stocks

Compare
1,575 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Akebia Therapeutics
$1.63
$429.89M
-15.10%
3 Buy
0 Hold
0 Sell
Strong Buy
Oruka Therapeutics
$31.40
$1.33B
-7.54
31.66%
10 Buy
0 Hold
0 Sell
Strong Buy
Theravance Biopharma
$17.61
$918.18M
31.66
75.40%
5 Buy
1 Hold
0 Sell
Strong Buy
Vir Biotechnology
$6.55
$915.44M
-19.04%
7 Buy
0 Hold
0 Sell
Strong Buy
ProKidney
$2.21
$664.84M
7.96%
0 Buy
1 Hold
1 Sell
Moderate Sell
ArriVent BioPharma, Inc.
$24.91
$1.02B
-5.83
-11.45%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AKBA
Akebia Therapeutics
1.63
-0.19
-10.44%
ORKA
Oruka Therapeutics
31.40
10.08
47.28%
TBPH
Theravance Biopharma
17.61
7.74
78.42%
VIR
Vir Biotechnology
6.55
-0.88
-11.84%
PROK
ProKidney
2.17
0.29
15.43%
AVBP
ArriVent BioPharma, Inc.
24.35
-1.53
-5.91%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts